John S. Welch

Active 1970–2025

49
Papers
21,940
Citations
37
h-index
47
i10-index

Citations

Citations per year for John S. Welch1974: 1 citations1976: 1 citations1978: 1 citations1979: 1 citations1980: 1 citations1984: 1 citations1985: 1 citations1987: 1 citations1989: 2 citations1991: 2 citations1992: 3 citations1993: 1 citations1994: 1 citations1997: 1 citations1998: 9 citations1999: 22 citations2000: 80 citations2001: 112 citations2002: 107 citations2003: 118 citations2004: 103 citations2005: 99 citations2006: 85 citations2007: 90 citations2008: 71 citations2009: 59 citations2010: 65 citations2011: 132 citations2012: 162 citations2013: 245 citations2014: 345 citations2015: 381 citations2016: 446 citations2017: 446 citations2018: 452 citations2019: 992 citations2020: 989 citations2021: 851 citations2022: 661 citations2023: 482 citations2024: 632 citations2025: 297 citations2026: 8 citations1975: no citations, so this year is not shown1977: no citations, so this year is not shown1981–1983: no citations, so these years are not shown1986: no citations, so this year is not shown1988: no citations, so this year is not shown1990: no citations, so this year is not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,767 citing papers, 32.6% of this breakdownChina: 998 citing papers, 8.6% of this breakdownUnited Kingdom: 791 citing papers, 6.9% of this breakdownGermany: 698 citing papers, 6% of this breakdownItaly: 474 citing papers, 4.1% of this breakdownFrance: 464 citing papers, 4% of this breakdownCanada: 385 citing papers, 3.3% of this breakdownJapan: 377 citing papers, 3.3% of this breakdownSpain: 331 citing papers, 2.9% of this breakdownNetherlands: 312 citing papers, 2.7% of this breakdownAustralia: 280 citing papers, 2.4% of this breakdownSweden: 218 citing papers, 1.9% of this breakdown
0%32.6%Other 21.3%

Fields

  • Medicine48.2%
  • Biochemistry, Genetics and Molecular Biology43.1%
  • Immunology and Microbiology5%
  • Computer Science1.2%
  • Neuroscience0.5%
  • Nursing0.5%
  • Other1.5%

Topics

  • Acute Myeloid Leukemia Research9.7%
  • Cancer Genomics and Diagnostics7.2%
  • Epigenetics and DNA Methylation4.6%
  • Peroxisome Proliferator-Activated Receptors2.9%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.7%
  • Hematopoietic Stem Cell Transplantation2.3%
  • Other70.6%

Coauthors

All papers

Open in search
  1. Mutational landscape and significance across 12 major cancer types

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2013 cited by 4,556

  2. Age-related mutations associated with clonal hematopoietic expansion and malignancies

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2014 cited by 1,887

  3. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 891

  4. DNMT3A Mutations in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gary W. Swift, Jerry P. Reed, Patricia A. Alldredge, Todd Wylie, Jason Walker, Joelle Kalicki, Mark A. Watson, Sharon E. Heath, William D. Shannon, Nobish Varghese, Rakesh Nagarajan, Peter Westervelt, Michael H. Tomasson, Daniel C. Link, Timothy A. Graubert, John F. DiPersio, Elaine R. Mardis, Richard K. Wilson - New England Journal of Medicine 2010 cited by 1,980

  5. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 471

  6. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhining Chen, Sherry Pierce, Jing Ning, Wei Qiao, Farhad Ravandi, Michael Andreeff, John S. Welch, Hagop M. Kantarjian, Marina Konopleva - The Lancet Haematology 2020 cited by 331

  7. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William D. Shannon, Jacqueline E. Payton, Shashikant Kulkarni, Peter Westervelt, Matthew J. Walter, Timothy A. Graubert, Elaine R. Mardis, Richard K. Wilson, John F. DiPersio - Nature 2012 cited by 2,027

  8. The Origin and Evolution of Mutations in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasreet Hundal, Lisa L. Cook, Gary W. Swift, Jerry P. Reed, Patricia A. Alldredge, Todd Wylie, Jason Walker, Mark A. Watson, Sharon E. Heath, William D. Shannon, Nobish Varghese, Rakesh Nagarajan, Jacqueline E. Payton, Jack Baty, Shashikant Kulkarni, Jeffery M. Klco, Michael H. Tomasson, Peter Westervelt, Matthew J. Walter, Timothy A. Graubert, John F. DiPersio, Li Ding, Elaine R. Mardis, Richard K. Wilson - Cell 2012 cited by 1,576

  9. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Madina Sukhanova, Randall W. Knoebel, Wendy Stock, Timothy A. Graubert, Matthew J. Walter, Peter Westervelt, Daniel C. Link, John F. DiPersio, Timothy J. Ley - New England Journal of Medicine 2016 cited by 784

  10. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wei Qiao, John S. Welch, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva - Haematologica 2020 cited by 173

  11. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

    Authors: , , , , , , , , , , , , , , , , - PLoS Computational Biology, PLoS Comput. Biol. 2014 cited by 495

  12. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 198

  13. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

    Authors: , , , , , , , , , - Nature 1999 cited by 854

  14. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2017 cited by 225

  15. Patterns and functional implications of rare germline variants across 12 cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew J. Walter, Matthew J. Ellis, Elaine R. Mardis, Timothy A. Graubert, John F. DiPersio, Timothy J. Ley, Richard K. Wilson, Paul J. Goodfellow, Benjamin J. Raphael, Feng Chen, Kimberly J. Johnson, Jeffrey D. Parvin, Li Ding - Nature Communications 2015 cited by 313

  16. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerald P. Radich, Daniel C. Link, Elaine R. Mardis, John F. DiPersio, Richard K. Wilson, Timothy J. Ley - JAMA 2015 cited by 341

  17. Mutation Clearance after Transplantation for Myelodysplastic Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 121

  18. Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

    Authors: , - Cancers 2019 cited by 75

  19. A global study for acute myeloid leukemia with RARG rearrangement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi-Xiang Wang, Yingchang Mi, Ying Lu, Zhen Cai, Zhan Su, David Taussig, Suzanne MacMahon, Edward D. Ball, Huan‐You Wang, John S. Welch, C. Cameron Yin, Gautam Borthakur, Miguel Á. Sanz, Hagop M. Kantarjian, Jinyan Huang, Jiong Hu, Suning Chen - Blood Advances 2023 cited by 26

  20. 15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 1,004

  21. Acute Myeloid Leukemia: The Good, the Bad, and the Ugly

    Authors: , , , , - American Society of Clinical Oncology Educational Book 2018 cited by 108

  22. Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasis

    Authors: , , , , , , , , , , , , , , - Blood 2022 cited by 24

  23. PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 424

  24. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 47